YL-0919

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
0120132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
YL-0919 has been identified as a novel dual 5-HT1A partial agonist and serotonin reuptake inhibitor. In the current study, we… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
BACKGROUND AND PURPOSE Our previous studies revealed that hypidone hydrochloride (YL-0919), which acts as a selective 5-HT… (More)
Is this relevant?
2014
2014
  • - Juan Qina, Hong-Xia Chena, +5 authors Yun-Feng Lia
  • 2014
This study aimed to explore the possible mechanisms underlying the antidepressant-like effect of YL0919, a novel antidepressant… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
It has been suggested that drugs combining activities of selective serotonin reuptake inhibitor and 5-HT1A receptor agonist may… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?